Seres Therapeutics Inc (MCRB.OQ)
MCRB.OQ on NASDAQ Stock Exchange Global Select Market
5.80USD
5:32pm GMT
5.80USD
5:32pm GMT
Change (% chg)
$0.15 (+2.65%)
$0.15 (+2.65%)
Prev Close
$5.65
$5.65
Open
$5.68
$5.68
Day's High
$5.80
$5.80
Day's Low
$5.57
$5.57
Volume
10,301
10,301
Avg. Vol
32,178
32,178
52-wk High
$11.30
$11.30
52-wk Low
$4.50
$4.50
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Roger Pomerantz |
61 | 2019 | Chairman of the Board |
Eric Shaff |
42 | 2019 | President, Chief Executive Officer, Director |
John Aunins |
57 | 2012 | Chief Technology Officer, Executive Vice President - Bioprocess and Manufacturing |
David Cook |
60 | 2012 | Chief Scientific Officer, Executive Vice President - Research & Development |
Thomas DesRosier |
63 | 2016 | Chief Legal Officer, Executive Vice President and Secretary |